Clinical Trials In Kansas

Discover hundreds of clinical trials in Kansas.
Search clinical trials in Kansas by condition or phase.

e.g. Respiratory Diseases

Kansas•Healthy volunteers: No

Filter results

Results: 85

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

West Plains, Washington, Troy, Springfieldshow 940 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Washington, Sunset Hills, Sullivan, Springfieldshow 350 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bone Scan

Cabozantinib S-malate

Computed Tomography

Ipilimumab

Magnetic Resonance Imaging

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Saint Peters, Saint Louis, Kansas City, Columbiashow 105 more

Code:

NCT06268873

Conditions

Chronic Kidney Disease and Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Baxdrostat/dapagliflozin

Dapagliflozin in combination with placebo

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Recruiting

Phase 3

Sponsor:

University of Rochester NCORP Research Base

Location:

Washington, Sunset Hills, Sullivan, Springfieldshow 270 more

Code:

NCT03996265

Conditions

Be Diagnosed With Cancer and Have Completed Systemic Therapy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bupropion Hydrochloride Controlled-release

Placebo Administration

Quality-of-Life Assessment

Questionnaire Administration

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Recruiting

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Washington, Sunset Hills, Sullivan, Springfieldshow 243 more

Code:

NCT04164082

Conditions

Bladder Urothelial Carcinoma In Situ

Invasive Bladder Mixed Carcinoma

Stage 0a Bladder Cancer AJCC v8

Stage 0is Bladder Cancer AJCC v8

Stage I Bladder Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Gemcitabine Hydrochloride

Pembrolizumab

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Recruiting

Phase 3

Sponsor:

National Cancer Institute (NCI)

Location:

Washington, Springfield, Saint Peters, Saint Louisshow 138 more

Code:

NCT04530565

Conditions

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Cytarabine

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial

Recruiting

Phase 3

Sponsor:

National Cancer Institute (NCI)

Location:

Washington, Sunset Hills, Sullivan, Springfieldshow 683 more

Code:

NCT04267848

Conditions

Lung Non-Small Cell Carcinoma

Lung Non-Small Cell Squamous Carcinoma

Lung Non-Squamous Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage IIIA Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Carboplatin

Cisplatin

Computed Tomography

Echocardiography

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

Phase 3

Sponsor:

NRG Oncology

Location:

Washington, Sunset Hills, Sullivan, Springfieldshow 624 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Recruiting

Phase 3

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Sunset Hills, Sullivan, Springfield, Sainte Genevieveshow 136 more

Code:

NCT05008848

Conditions

Cigarette Smoking-Related Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Smoking Cessation Intervention

Health Promotion and Education

Informational Intervention

Questionnaire Administration

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

Recruiting

Phase 2

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Washington, Springfield, Saint Peters, Saint Louisshow 291 more

Code:

NCT03994796

Conditions

CDK Gene Mutation

Metastatic Malignant Neoplasm in the Brain

Metastatic Malignant Solid Neoplasm

NTRK Family Gene Mutation

PI3K Gene Mutation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Abemaciclib

PI3K Inhibitor paxalisib

Entrectinib

Adagrasib

e.g. Respiratory Diseases

Kansas•Healthy volunteers: No

Filter results

Results: 85

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

West Plains, Washington, Troy, Springfieldshow 940 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Washington, Sunset Hills, Sullivan, Springfieldshow 350 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bone Scan

Cabozantinib S-malate

Computed Tomography

Ipilimumab

Magnetic Resonance Imaging

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Saint Peters, Saint Louis, Kansas City, Columbiashow 105 more

Code:

NCT06268873

Conditions

Chronic Kidney Disease and Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Baxdrostat/dapagliflozin

Dapagliflozin in combination with placebo

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Recruiting

Phase 3

Sponsor:

University of Rochester NCORP Research Base

Location:

Washington, Sunset Hills, Sullivan, Springfieldshow 270 more

Code:

NCT03996265

Conditions

Be Diagnosed With Cancer and Have Completed Systemic Therapy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bupropion Hydrochloride Controlled-release

Placebo Administration

Quality-of-Life Assessment

Questionnaire Administration

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Recruiting

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Washington, Sunset Hills, Sullivan, Springfieldshow 243 more

Code:

NCT04164082

Conditions

Bladder Urothelial Carcinoma In Situ

Invasive Bladder Mixed Carcinoma

Stage 0a Bladder Cancer AJCC v8

Stage 0is Bladder Cancer AJCC v8

Stage I Bladder Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Gemcitabine Hydrochloride

Pembrolizumab

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Recruiting

Phase 3

Sponsor:

National Cancer Institute (NCI)

Location:

Washington, Springfield, Saint Peters, Saint Louisshow 138 more

Code:

NCT04530565

Conditions

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Cytarabine

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial

Recruiting

Phase 3

Sponsor:

National Cancer Institute (NCI)

Location:

Washington, Sunset Hills, Sullivan, Springfieldshow 683 more

Code:

NCT04267848

Conditions

Lung Non-Small Cell Carcinoma

Lung Non-Small Cell Squamous Carcinoma

Lung Non-Squamous Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage IIIA Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Carboplatin

Cisplatin

Computed Tomography

Echocardiography

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

Phase 3

Sponsor:

NRG Oncology

Location:

Washington, Sunset Hills, Sullivan, Springfieldshow 624 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Recruiting

Phase 3

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Sunset Hills, Sullivan, Springfield, Sainte Genevieveshow 136 more

Code:

NCT05008848

Conditions

Cigarette Smoking-Related Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Smoking Cessation Intervention

Health Promotion and Education

Informational Intervention

Questionnaire Administration

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

Recruiting

Phase 2

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Washington, Springfield, Saint Peters, Saint Louisshow 291 more

Code:

NCT03994796

Conditions

CDK Gene Mutation

Metastatic Malignant Neoplasm in the Brain

Metastatic Malignant Solid Neoplasm

NTRK Family Gene Mutation

PI3K Gene Mutation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Abemaciclib

PI3K Inhibitor paxalisib

Entrectinib

Adagrasib